Description: This session from the 1992 Valuation Actuary Symposium looks at issues concerned with Life and Annuity Valuation, specifically meeting the 50 States Requirements, meeting the NAIC Actuarial Guidelines of valuation requirements, Guideline XXX and its implications and the use of new optional 15-year select factors to be applied to the 1980 CSO.

Description: This session from the 1993 Valuation Actuary Symposium looks at asset models and economic scenario generation.

Description: This is the table of contents for the 1994 Valuation Actuary Symposium.

Description: This session from the 1994 Valuation Actuary Symposium focuses on long-term projections of health insurance, the uses of the projections, the type of model to use and model considerations for the projections.

Description: Presented at September 1994 Valuation Actuary Symposium. Discusses analyzing and projecting financial risk in group health plans.

Description: Valuation Actuary Symposium This is a session on cash flow testing issues in small companies.

Description: 1996 Valuation Actuary Symposium. This session about life and annuity valuation issues discussed Guideline 33, Guideline MMM, separate accont surplus, equity-indexed annuities, the annuity mortality regulation, the model illustration regulation, and XXX.

Description: This 1997 Valuation Actuary Symposium, Session 14 looks at sources of profits and how that can be use in managing the company.

Description: This session at the 1998 Valuation Actuary Symposium looks at how companies can use the cash-flow testing structure for additional analysis and be more useful to the managment of the company. The concept of transfer pricing within a life company is explained.

Description: From a session at the 2000 Valuation Actuary Symposium held in Washington DC, September 14-15, 2000 The National Association of Insurance Commissioners NAIC Valuation of Life Insurance Policies Model Regulation XXX sets forth the valuation requirements for life insurance with nonlevel premiums or nonlevel benefits, including term insurance and universal life with certain underlying guarantees. Panelists discussed the issues around implementation of the requirements. The issues discussed include: • Determination of X factors when no credible company mortality exists • Proper treatment of secondary guarantees in universal life insurance • Preparation of the mortality assumption opinion requirements • Impacts on product development and design